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Introduction
Adipose tissue is a heterogeneous tissue. White adipose tissue 
(WAT) is the major site of energy storage and is mainly located 
in subcutaneous and intra-abdominal locations, whereas brown 
adipose tissue (BAT) is involved in energy utilization through the 
expression of uncoupling protein-1 (UCP1) (1–5). In rodents, the 
largest BAT depot is localized in the interscapular region, whereas 
in humans, BAT depots are localized to the neck and the supra-
clavicular and mediastinal regions (6). In addition, there is a pool 
of inducible brown adipocytes mixed in with WAT depots that is 
sometimes referred to as beige or brite fat (7–10).
Alterations in fat mass and distribution can have a major im-
pact on whole-body metabolism. Both obesity (increased WAT) 
and lipodystrophy (abnormal fat accumulation) lead to increased 
risk of type 2 diabetes and cardiovascular disease — 2 major causes 
of mortality and morbidity worldwide (11–13). Different WAT de-
pots play different roles in these metabolic defects. Accumulation 
of visceral, i.e., intra-abdominal, WAT is associated with the met-
abolic syndrome, whereas accumulation of subcutaneous WAT 
presents little risk and may even offer some protection against 
metabolic and cardiovascular complications (14). Recent studies 
have indicated that adult humans have active BAT (1–3), and stud-
ies in rodents have suggested that this constitutive BAT and the 
inducible beige/brite fat may be potential targets for promoting 
weight loss and improving glucose metabolism (15–18).
miRNAs play important roles in many biological processes (19, 
20) and have been proposed to play a major role in the differentiation 
and function of both white and brown fat (21). The miR-193b-365 
cluster of miRNAs and miR-155 participate in brown adipogene-
sis (22, 23), while miR-143 and miR-103 have been implicated in 
white adipocyte differentiation and insulin resistance (24–26). 
Likewise, miR-133 acts to repress Prdm16 in common adipocyte/
muscle precursor cells to favor the myogenic over the brown adi-
pogenic program (27, 28), while miR-196a, which is expressed pri-
marily in WAT progenitor cells in response to cold or adrenergic 
stimulation, can suppress the white fat gene HoxC8 post-transcrip-
tionally to favor brown adipogenesis over white adipogenesis (29).
Recently, we have shown that many miRNAs are markedly 
downregulated in the WAT of mice as they age (30). These changes 
are due to a decrease in expression of the miRNA-processing en-
zyme dicer and can be reversed by caloric restriction, a condition 
that is known to prolong lifespan. They can also be mimicked in 
preadipocytes in culture by exposure to oxidative and UV stress. A 
decline in dicer and miRNA processing with age is also observed in 
cultured human preadipocytes and in C. elegans, where it is linked 
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also no reduction in dicer levels in other nonadipose tissues, in-
cluding muscle and liver.
On a chow diet, Adicer-KO mice had body weight (Figure 1A) 
and length (Supplemental Figure 1, A and B; supplemental ma-
terial available online with this article; doi:10.1172/JCI73468DS1) 
similar to those of Lox controls over the first 8 months of life; how-
ever, this was accompanied by a significant change in body com-
position. Dual-energy x-ray absorptiometry (DEXA) at 8 months 
of age revealed a 71% decrease in fat mass and a 28% increase in 
lean mass of the Adicer-KO mice (Figure 1B and Table 1). Despite 
the decrease in overall fat mass, MRI indicated enlargement of 
the interscapular fat depot (Figure 1C and Supplemental Figure 
1C). These changes in fat mass and distribution were confirmed at 
sacrifice, which revealed 41% and 73% decreases in weight of the 
subcutaneous (flank) and intra-abdominal fat pads, but a greater 
than 2-fold increase in the mass of the interscapular brown fat pad 
(Figure 1, D and E, and Supplemental Figure 1D).
When placed on a 60% high-fat diet (HFD), the alterations 
in fat distribution and body composition in Adicer-KO mice were 
further exaggerated. Thus, Adicer-KO mice did not gain as much 
weight as their littermate controls (Figure 1F) and demonstrated 
a clearly abnormal fat distribution, with relatively little accumula-
tion of subcutaneous and intra-abdominal fat (Figure 1, D and E), 
but clear enlargement of the interscapular and suprascapular fat 
pads (Figure 1, D, E, and G). After 5 months on an HFD, the con-
trol mice showed 2- to 3-fold increases in the weight of all fat pads 
when compared with those of mice of the same age on a chow diet 
(Figure 1E). In contrast, the weights of white fat depots (epididy-
mal, flank, mesenteric, and perirenal) in Adicer-KO mice did not 
change or even decreased after an HFD, with a reduction of 62% to 
94% in comparison with those of controls on an HFD. On the other 
hand, there was an increase in fat accumulation in the interscapu-
lar region of Adicer-KO mice on an HFD, with a 4.5-fold increase in 
the interscapular brown fat pad when compared with that of con-
trols on the same diet (Figure 1E). Interestingly, the suprascapular 
white adipose depot adjacent to the interscapular BAT, which is be-
tween the classical white and brown depots, showed no significant 
increase or decrease. We observed no differences in other organ 
to an increased susceptibility of the organism to stress. Aging and 
caloric restriction also impact adipocyte differentiation and func-
tion and through this and other mechanisms affect the risk of de-
velopment of metabolic diseases (31, 32).
In the present study, we show that mice with a tissue-specific 
KO of dicer in adipose tissue develop a form of lipodystrophy 
characterized by decreased WAT mass and an increase and “whit-
ening” of the interscapular BAT mass. These phenotypes are ac-
companied by insulin resistance, adipose tissue inflammation, dy-
slipidemia, and other systemic features that resemble the human 
HIV–associated lipodystrophy syndrome. Consistent with this ob-
servation, dicer mRNA expression is reduced in the adipose tissue 
of HIV patients. Taken together, our data indicate an essential role 
for adipose tissue dicer and miRNA processing in control of brown 
and white fat determination and whole-body metabolism, and this 
may contribute to the pathogenesis of HIV-related lipodystrophy.
Results
Fat-specific dicer-KO mice exhibit abnormal fat accumulation. To 
explore the role of dicer and miRNAs in adipose tissue in vivo, we 
created mice with conditional inactivation of the dicer allele in 
adipose tissue. To this end, we bred mice carrying the dicer floxed 
allele with mice carrying the aP2-Cre transgene (33), however, this 
resulted in a high degree of early postnatal lethality, and those 
mice that did survive the first week of life were runted and died by 
1 month of age. The low yield and poor health of these aP2-Cre– 
induced dicer-KO mice is consistent with the previous report 
by Mudhasani et al. (34) and is almost certainly due to the early, 
off-target expression of the aP2-Cre transgene, i.e., expression in 
tissues other than adipose, as was recently reported (35). Indeed, 
this lethality could be overcome by creating a fat-directed dicer 
KO using the Cre recombinase gene driven by the adiponectin 
promoter (Adicer-KO). Different from the aP2-Cre dicerfl/fl mice, 
the Adicer-KO mice were born at normal Mendelian ratios, had 
no gross abnormalities, and were viable up to more than 1 year 
of age. We performed quantitative RT-PCR (RT-qPCR) in tissues 
from 3-month-old mice, which revealed reductions of dicer mRNA 
by 61%, 70%, and 81% in subcutaneous WAT, perigonadal WAT, 
and BAT, respectively. On tissue fractionation, this decrease was 
entirely due to decreases in dicer in the adipocyte fraction, with no 
change in dicer levels in the stromovascular cells (30). There was 
Figure 1. Partial lipodystrophy in fat-specific Adicer-KO mice. (A) Ten-
week-old Adicer-KO and Lox control mice were maintained on a chow diet 
for 5 months, and body weight was monitored (n = 5–12 animals per group). 
(B) Eight-month-old mice on a chow diet were subjected to a DEXA scan, 
and fat and lean mass was calculated (n = 5–6 mice per group). (C) MRI was 
performed in 4-month-old mice fed a chow diet. Images show a sagittal 
plane representative of 1 mouse of 2 per genotype. Fat is indicated by the red 
demarcation. (D–H) Ten-week-old Adicer-KO and Lox control mice were put 
on an HFD or maintained on a chow diet for 5 months prior to sacrifice  
(n = 6–12 animals per group). (D) Images of representative fat tissues. (E) 
Tissue weight at time of sacrifice. (F) Body weight was assessed weekly. (G) 
Dorsal view of mice showing a “buffalo hump” after 5 months on an HFD. (H) 
H&E staining of fat samples. Representative images (original magnification, 
×200) of at least 3 animals per group. *P < 0.05. Values are the mean ± SEM. 
SQ (flank), subcutaneous WAT of the flank region; SQ (SS), subcutaneous 
WAT of the suprascapular region; BAT, interscapular BAT. Epididymal, me-
senteric, and perirenal represent different depots of intra-abdominal WAT.
Table 1. Body composition of Adicer-KO mice
Lox Adicer-KO
Mean ± SEM Mean ± SEM
Total
BW (g) 37.88 ± 4.08 38.43 ± 1.08
Total (g) 37.73 ± 3.98 38.35 ± 0.96
Fat (g) 13.80 ± 2.74 7.70 ± 0.60
Lean (g) 23.98 ± 1.52 30.65 ± 0.61A
% Fat 35.00 ± 4.27 19.98 ± 1.23A
Abdomen
Total (g) 10.5 ± 1.1 10.3 ± 0.3
Fat (g) 4.08 ± 0.81 1.20 ± 0.06A
Lean (g) 6.35 ± 0.35 9.05 ± 0.27A
% Fat 37.50 ± 4.45 11.85 ± 0.46A
Eight-month-old mice were subjected to DEXA scanning. Total, calculated 
total mass. AP < 0.05. n = 5–6 mice per group.
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mice (neither reached statistical significance), suggesting that BAT 
is the primary site for fat accumulation in Adicer-KO mice.
Another striking phenotype of the brown fat depot of Adicer-KO 
mice was its color. While control interscapular adipose tissue had 
weights (Figure 1E). Liver histology was similar between Adicer-
KO and Lox mice (Supplemental Figure 1E). We found that hepatic 
(Supplemental Figure 1F) and muscle (Supplemental Figure 1G) tri-
glyceride content was only slightly higher in Adicer-KO than in Lox 
Figure 2. Adicer-KO mice are insulin resistant. (A) Four-month-old mice fed a chow diet were i.v. injected with either saline or insulin (10 U), and AKT and 
ERK phosphorylation were assessed by Western blotting in the flank subcutaneous adipose tissue. (B, E, and F) Ten-week-old Adicer-KO and Lox control 
mice were put on an HFD or maintained on a chow diet for 5 months prior to sacrifice (6–12 animals per group). (B) Gene expression analysis in the flank 
subcutaneous adipose tissue. (C) Lipogenesis and (D) lipolysis were assessed in isolated adipocytes of the subcutaneous adipose tissue of the flank region 
of 4-month-old mice on a chow diet (n = 8 per group). *P < 0.05. (E) An i.p. ITT was performed using 1 U insulin/kg body weight injection and expressed 
as a percentage of basal blood glucose level. (F) An i.p. glucose tolerance test using 2 g glucose/kg body weight. *P < 0.05 versus Lox; #P < 0.05 versus 
chow diet. (G–I) Hyperinsulinemic-euglycemic clamps were performed in conscious 5-month-old Adicer-KO and Lox control mice (6 animals per group). (G) 
Glucose infusion rate represents the amount of exogenous glucose required to maintain blood glucose levels during a hyperinsulinemic state. (H) Hepatic 
glucose production was calculated based on the endogenous production of glucose during basal or hyperinsulinemic (clamp) states. (I) Glucose uptake by 
indicated tissues during hyperinsulinemic state. Values are the mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001.
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and an approximately 50% reduction in 
serum leptin in mice on chow and HFDs, 
although the latter did not quite reach statis-
tical significance. Despite the increase in 
inflammation in adipose tissue, serum IL-6 
levels did not change, but other adipokines 
associated with cardiovascular disease risk, 
such as plasminogen activator inhibitor-1 
(PAI-1) and monocyte chemotactic protein-1 
(MCP-1), were increased in Adicer-KO mice, 
especially in mice on an HFD (Table 2). 
Adicer-KO mice also showed signs of dys-
lipidemia with high serum triglycerides and 
FFAs and a 4.5-fold increase in circulating 
insulin levels (Table 2). Consistent with hy-
perinsulinemia, Adicer-KO mice on a chow 
diet exhibited increased basal and glucose-
stimulated insulin secretion (Supplemental 
Figure 3F) and insulin resistance by insulin 
tolerance testing (ITT) (Figure 2E and Sup-
plemental Figure 3G). In these mice, the 
increased insulin balanced the insulin resistance, so that glucose 
tolerance in the chow-fed animals was normal (Figure 2F).
To explore the causes of insulin resistance in Adicer-KO mice, 
these mice were subjected to hyperinsulinemic-euglycemic clamps 
in the conscious state. Consistent with the ITT data, we found that 
the glucose infusion and whole-body glucose turnover rates during 
the clamp were decreased in Adicer-KO mice (Figure 2G and Supple-
mental Table 1). This was associated with an inability of insulin to sup-
press hepatic glucose production (Figure 2H) and marked decreases 
in glucose uptake in BAT (72% reduction) and WAT (39% reduction) 
in Adicer-KO mice as compared with that in controls (Figure 2I). We 
also observed a trend toward decreased glucose uptake in skeletal 
muscle and a significant reduction in heart glucose uptake in Adicer-
KO mice (Supplemental Table 1). This insulin resistance was further 
exacerbated by an HFD in Adicer-KO mice (Figure 2E), resulting in 
clear hyperglycemia in the fed state (0 time point of the ITT in Supple-
mental Figure 3G). The Adicer-KO mice also had mild elevations of 
fasting glucose, but were somewhat more glucose tolerant than were 
the controls (Figure 2F), reflecting the combined effects of reduced 
fat, increased lean mass, and increased insulin levels. Together, these 
findings indicate that dicer KO in adipose tissue results in a form of 
partial lipodystrophy that resembles features of the human HIV– 
related partial lipodystrophy syndrome. These features include redis-
tribution of fat depots, insulin resistance, adipose tissue inflamma-
tion, dyslipidemia, and markers of cardiovascular disease risk.
Increased resting energy expenditure despite whitening of adipose 
tissue in Adicer-KO mice. In metabolic cage assessment of female 
Adicer-KO mice on a chow diet, we found that food intake and ac-
tivity were similar (Supplemental Figure 4A and B), but there was 
a mild increase in O2 consumption (Figure 3A), heat production 
(Supplemental Figure 4C), and respiratory exchange ratio (Sup-
plemental Figure 4D) between Adicer-KO mice and controls fed 
a chow diet, indicating an increase in resting energy expenditure. 
Male mice also had an increase in resting energy expenditure, but 
this was accompanied by a mild decrease in spontaneous activity 
(Supplemental Figure 4, E and F).
a classical brown-red color, the same fat pads in Adicer-KO mice 
were cream colored (Figure 1D). Histological analysis of this tissue 
revealed adipocytes with mixed white-brown characteristics with 
both unilocular and multilocular fat droplets (Figure 1H). WAT de-
pots in Adicer-KO mice showed large, unilocular adipocytes similar 
to those of controls, but in the epididymal depot, there was increased 
fibrosis and inflammation-related crown-like structures (Figure 1H, 
right panels, and Supplemental Figure 1E). Consistent with this, we 
observed increased macrophage infiltration in the epididymal WAT 
of Adicer-KO mice, as evidenced by Cd68 expression (Supplemental 
Figure 2A) and F4/80 immunostaining (Supplemental Figure 2B).
Adicer-KO mice have signs of the human HIV–related partial lipo-
dystrophy syndrome. Abnormal fat accumulation and increased in-
flammation in adipose tissue are usually associated with insulin re-
sistance and are also observed in some patients with lipodystrophy 
(36–39). Indeed, following insulin stimulation in vivo, while control 
mice showed robust AKT and ERK phosphorylation in white and 
brown fat depots, insulin-stimulated AKT and ERK phosphoryla-
tion was severely impaired in the Adicer-KO mice (Figure 2A and 
Supplemental Figure 3A). In addition, we found that genes in-
volved in glucose (Glut4) or lipid (Srebp1c, Fas, Atgl, Hsl, and Lpl) 
metabolism and the genes encoding leptin and adiponectin were 
downregulated by 59% to 83% in the white fat of chow-fed Adicer-
KO mice and were even more downregulated in the HFD-fed ani-
mals (Figure 2B and Supplemental Figure 3B). By contrast, in inter-
scapular BAT, with the exception of Glut4, these mRNAs did not 
show significant differences (Supplemental Figure 3C). Consistent 
with decreased insulin signaling and the altered gene expression 
pattern, basal and insulin-induced lipogenesis in WAT and BAT 
was decreased by greater than 75% and by greater than 90%, re-
spectively (Figure 2C and Supplemental Figure 3D). Isoproterenol- 
induced lipolysis was also impaired in the WAT of Adicer-KO mice, 
with a 63% reduction (Figure 2D and Supplemental Figure 3E).
White fat secretes adipokines that control whole-body metab-
olism and disease susceptibility (40, 41). In Adicer-KO mice, we 
observed a 57%–74% decrease in circulating adiponectin (P < 0.05) 
Table 2. Serum profile of Adicer-KO mice
Chow diet HFD
Lox Adicer-KO Lox Adicer-KO
Hormones Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM
Insulin (ng/ml) 1.51 ± 0.57 6.77 ± 1.52A 2.35 ± 0.88 3.99 ± 1.02
IGF-1 (ng/ml) 282.95 ± 31.87 385.54 ± 25.52A 322.56 ± 29.43 396.57 ± 22.83
T3 (pg/ml) 686.43 ± 57.90 841.18 ± 69.18 675.25 ± 31.78 755.33 ± 90.97
Adipokines
Leptin (ng/ml) 17.49 ± 6.64 9.76 ± 1.04 40.88 ± 10.96 20.05 ± 3.67
Adiponectin (μg/ml) 7.43 ± 1.42 3.96 ± 0.61A 12.55 ± 1.25 3.31 ± 0.95A
IL-6 (pg/ml) 8.85 ± 1.44 8.25 ± 1.37 6.33 ± 1.84 12.44 ± 2.50
MCP-1 (pg/ml) 9.17 ± 1.65 14.05 ± 3.37 15.78 ± 5.29 58.14 ± 11.63A
PAI-1 (ng/ml) 0.63 ± 0.10 1.70 ± 0.26A 0.69 ± 0.24 2.08 ± 0.41A
Lipids and cholesterol
Triglycerides (mg/dl) 81.12 ± 11.71 111.57 ± 5.14A 63.16 ± 4.29 94.45 ± 11.17A
FFA (mEq/ml) 1.50 ± 0.18 1.98 ± 0.10A 1.33 ± 0.09 1.38 ± 0.11
Cholesterol (mg/dl) 131.54 ± 6.83 133.34 ± 4.43 175.92 ± 5.50 165.69 ± 8.04
AP < 0.05 versus Lox control. n = 6–11 mice per group.
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Histological studies and measurement of brown and white fat 
markers in the interscapular BAT were consistent with whitening of 
this depot in the Adicer-KO mice. Thus, while the “brown” adipo-
cytes showed a markedly increased size of their lipid droplets, often 
resembling white adipocytes, all of the cells in the interscapular fat 
pad stained positively for UCP1, although the level appeared reduced 
(Figure 3B). This decrease in UCP1 expression was confirmed by 
Western blotting (Figure 3C) and qPCR (Figure 3D) and was accom-
panied by an increased expression of WAT markers such as leptin and 
HoxC9 (Figure 3D). Other brown fat markers, such as Elovl3 and Cidea 
mRNAs, were also reduced in the BAT of Adicer-KO mice, while lev-
els of Dio2, Prdm16, and Pgc1a mRNAs were unchanged (Figure 3D). 
Despite the low basal levels of Ucp1 and Elovl3 in the Adicer-KO mice, 
both the KO and control mice showed similar fold increases in these 
mRNAs in response to chronic cold exposure (Figure 3D), and this 
was confirmed at the protein level for UCP1 (Figure 3C). Consistent 
with whitening of the brown fat, the increases in O2 consumption 
(Figure 3E) and temperature (Figure 3F) following injection with the 
β3-adrenergic receptor agonist CL-316,243 were blunted in Adicer-
KO mice. However, Adicer-KO mice were able to maintain their body 
temperature during cold exposure as well as, or even better than, 
controls (Figure 3G), indicating that these mice develop a compensa-
tory response to overcome their brown fat deficiency. Indeed, even in 
young (6- to 8-week-old) mice, when no differences in white fat dis-
tribution or lipodystrophy were observed (Supplemental Table 2 and 
Supplemental Figure 5A), Adicer-KO mice were more thermotolerant 
than or as thermotolerant as Lox controls during acute (Figure 3H) 
and chronic cold exposure (Supplemental Figure 5B), despite having 
decreased BAT mass and decreased Ucp1 and Elovl3 mRNA expres-
sion in both BAT and flank subcutaneous WAT after the chronic cold 
exposure (Supplemental Figure 5, C–E). This appeared to be due to a 
marked increase in shivering in Adicer-KO mice during cold exposure 
(Figure 3I). Thus, Adicer-KO mice compensate their impaired brown 
adipose function with increased shivering, a high energy–demand-
ing process that contributes to increased resting energy expenditure 
and helps maintain body temperature. Also, despite these alterations 
in energy expenditure and the evolving features of metabolic syn-
drome, at both 6 and 16 months of age, the Adicer-KO mice were able 
to withstand a challenge with the oxidative toxin paraquat as well as 
or slightly better than did controls (Supplemental Figure 5, F and G), 
consistent with a link between adipose tissue miRNA processing and 
longevity and stress resistance (30).
As noted above, in addition to the interscapular preformed 
BAT in mice, there is a pool of inducible brown adipocytes, re-
ferred to as beige or brite adipocytes, mixed in with white adipose 
depots  (7, 9, 10, 42, 43). In both the Adicer-KO and control mice, 
we observed that subcutaneous WAT had very low levels of UCP1, 
which increased in response to cold exposure, but in the Adicer-
KO mice, this increase in UCP1, i.e., recruitment of beige adipo-
cytes, was impaired (Figure 3J and Supplemental Figure 5E). Thus, 
normal miRNA processing is required for the development and 
function of interscapular BAT as well as for browning of WAT.
Downregulation of dicer in adulthood leads to fat redistribution 
and insulin resistance. To determine whether the effects of dicer de-
ficiency in adipocytes were exclusively a developmental phenom-
enon or could be acquired during adulthood, we created a second 
model in which dicer was knocked down in fat using a tamoxifen-in-
duced aP2-Cre transgene (iaP2dicer-KO). Although the inducible 
aP2-Cre does not produce as effective a recombination as the ad-
iponectin-Cre (35), this avoided the early lethality of the aP2-Cre 
dicerfl/fl mice and allowed us to use tamoxifen induction in the mice 
from 3 months until 8 months of age. In this model, we found an 
approximately 40% decrease in dicer mRNA in the fat depots of the 
dorsocervical region (i.e., interscapular brown and suprascapular 
white), but no significant changes in dicer expression levels in other 
subcutaneous or intra-abdominal depots (Figure 4A). Although 
there was no change in the size of most fat pads or nonadipose tis-
sues in this mouse, consistent with the Adicer-KO phenotype, the 
iaP2dicer-KO mice exhibited approximately 70% enlargement of 
interscapular BAT (Figure 4, B–D). This was accompanied by a par-
allel decrease in UCP1 levels in the interscapular BAT (Figure 4E) 
and systemic insulin resistance as measured by a fall in glucose dur-
ing i.p. ITT (Figure 4F). These mice also had increased lean mass 
(Supplemental Table 3) and showed a trend toward hyperinsuline-
mia and hypertriglyceridemia (Supplemental Table 4), also mimick-
ing features of the Adicer-KO mice. Thus, downregulation of dicer 
in adulthood can lead to abnormal fat distribution with a partial loss 
of brown adipocyte identity, increased lean mass, and development 
of some features of the metabolic syndrome.
Whitening of dicer-KO brown adipocytes in vitro. To explore the 
mechanisms underlying the change in brown adipocyte identity in 
the dicer-KO mice and to determine whether the effect was cell auton-
omous, preadipocytes were isolated from the interscapular adipose 
tissue of mice carrying the floxed dicer allele (dicerfl/fl), immortalized 
using SV-40-large T antigen, and subjected to gene recombination 
ex vivo by infection with Cre- or GFP-bearing adenoviruses. This re-
sulted in a greater than 95% decrease in dicer expression at the mRNA 
level (Supplemental Figure 6A). In vitro, these dicer-KO preadipo-
cytes differentiated into adipocytes as well as the control cells did, as 
evidenced by the similar levels of the pan-adipocyte markers Pparg, 
Cebpa, and aP2 (Figure 5A) and by the Oil Red O staining for lipid ac-
cumulation (Figure 5, B and C). However, there appeared to be fewer 
Figure 3. Bioenergetic profile and brown fat whitening in Adicer-KO 
mice. (A) Six-month-old female mice were subjected to comprehensive lab 
animal monitoring system (CLAMS) analysis, in which O2 consumption was 
measured (n = 4 mice per group). Mice were fasted during the last 24 hours 
of the experiment. Values were normalized by lean mass. (B) UCP1 immu-
nohistochemistry (IHC) of interscapular BAT from 4-month-old mice at 
room temperature (23°C). UCP1 staining (brown, cytoplasmic); hematoxylin 
counterstaining (blue, nuclear). Images (original magnification, ×400) are 
representative of at least 3 mice per group. (C and D) Four-month-old mice 
were subjected to 4-day chronic exposure to 6°C (n = 5 mice per group). 
(C) UCP1 expression in interscapular BAT from mice at room temperature 
(RT) or after chronic cold exposure (Cold) as assessed by Western blotting. 
β-Tubulin was used as the loading control. (D) Markers of brown and white 
adipocytes were assessed in the interscapular BAT by qPCR. (E and F) Five-
month-old mice were injected with CL-316,243, and (E) O2 consumption and 
(F) rectal temperature were measured (n = 4–8 mice per group). (G and H) 
Rectal temperature of 4-month-old or 2-month-old mice was measured 
during exposure to 6°C (G, n = 5 mice per group; H, n = 5–6 mice per group). 
(I) Shivering time of 2-month-old mice during a 1-minute period after 
36 hours of cold (6°C) exposure (n = 5–6 mice per group). (J) UCP1 IHC of 
inguinal WAT from 4-month-old mice subjected to 4 days of cold exposure 
(n = 5 mice per group). UCP1 staining with hematoxylin counterstaining. 
Representative images (original magnification, ×400) of at least 3 mice per 
group. *P < 0.05; ***P < 0.001. Values are the mean ± SEM.
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ysis (GSEA), we found targets of the let-7 family, miR-346, miR-365, 
miR-154, miR-455, the miR-25 and miR-26 families, and miR-362 to 
be significantly upregulated in dicer-KO cells (Supplemental Table 
5). As expected, we found that all these miRNAs were significantly 
reduced in the dicer-KO preadipocytes compared with those in the 
Lox control preadipocytes (Supplemental Figure 8A), with the excep-
tion of miR-25, which was not above the level of detection in pread-
ipocytes. While reintroduction of miR-154, miR-346, and miR-362 
had no significant effect on Ucp1 mRNA expression in the KO cells, 
expression of miR-365 was able to increase levels of Ucp1 mRNA by 
20-fold in the KO cells, reversing the low levels, and also increased 
levels of Ucp1 in the Lox cells by almost 3-fold (Figure 5F). This oc-
curred with no effect on adipogenesis as measured by the ability of 
the cells to accumulate lipids (Supplemental Figure 8B). The differ-
ential expression of HoxC9 mRNA, a WAT marker, between KO and 
control cells also tended to diminish with transfection of the miR-365 
mimic, but was not restored to normal levels (Supplemental Figure 
8C), and other markers of brown and white adipocyte identity, like 
Elovl3 and leptin, were not modified by the reexpression of miR-365 
(Supplemental Figure 8C). Reexpression of miR-346 and miR-362 in 
the dicer-KO cells, on the other hand, partially reversed the decrease 
in Cebpb, a key switch in the brown adipogenic gene expression pro-
gram (ref. 29 and Figure 5G). These results are consistent with the 
notion that the cell-autonomous phenotypes of dicer-KO cells are 
dicer-KO cells overall after differentiation, and this was confirmed 
by a 28% decrease of DNA content in the plate (Supplemental Fig-
ure 6B). This is consistent with a role for dicer and mRNA process-
ing in cell replication and stress response (30). More importantly, 
after differentiation, dicer-KO brown preadipocytes expressed 
lower levels of the brown adipocyte–specific genes Ucp1 and Elovl3 
and higher levels of the white adipocyte marker leptin (Figure 5A). 
As in vivo, dicer-KO adipocytes were responsive to β-adrenergic and 
cyclic AMP (cAMP) stimulation, but even under these conditions the 
level of Ucp1 mRNA remained at about 60% of that of the control cells 
(Figure 5D). When compared with the Lox control cells, these cells 
also had an approximately 25% reduction in the level of uncoupled 
respiration rate, as assessed in a Seahorse Flux Analyzer (Figure 5E), 
but showed no alterations in basal respiration, maximal respiratory 
capacity, or nonmitochondrial respiration (Supplemental Figure 7). 
Thus, brown preadipocytes with ablation of dicer in vitro show a par-
tial shift in identity from brown to white, i.e., the effect was cell au-
tonomous, but as in vivo, these cells preserved some characteristics 
of normal brown adipocytes, including their response to upregulate 
UCP1 following adrenergic stimulation.
To determine which miRNAs might play a role in the dicer-
KO phenotype, we examined the mRNAs upregulated in dicer-KO 
preadipocytes (GEO GSE24683) and asked whether there were en-
riched miRNA targets among them. Using gene set enrichment anal-
Figure 4. Characterization of inducible fat–specific Adicer-KO (iaP2dicer-KO) mice. Mice carrying the Cre recombinase gene driven by a tamoxifen-in-
duced aP2 promoter or their littermate Lox controls were given 3 mg tamoxifen weekly from 3 to 8 months of age (n = 6–7 mice per group). (A) Expression 
of dicer mRNA as assessed by qPCR. (B–D) Tissue weights normalized to body weight for (B) interscapular BAT, (C) WAT depots, and (D) nonadipose 
tissues. (E) UCP1 expression in interscapular BAT. β-Tubulin was used to control for protein concentration. The β-tubulin immunoblot was performed with 
samples run on a separate gel. (F) ITT using i.p. injection of 1 U insulin/kg body weight. *P < 0.05. Values are the mean ± SEM. SQ fat, subcutaneous WAT 
of the flank region; SS fat, subcutaneous WAT of the suprascapular region; BAT, interscapular BAT; PG fat, perigonadal (epididymal) WAT; RP fat, retroperi-
toneal WAT; Quad, quadriceps skeletal muscle.
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partial lipodystrophy, especially in patients with HIV-related lipo-
dystrophy (36–39, 44–47). To determine whether the latter might 
be linked to dicer downregulation, we analyzed biopsies of subcu-
taneous fat depots from the dorsocervical and abdominal regions 
of 2 independent cohorts of controls and HIV patients undergoing 
antiretroviral treatment (Supplemental Tables 6 and 7). One cohort 
was from Boston and had biopsies of the dorsocervical region (48); 
the other was from Finland and had biopsies from subcutaneous 
likely a consequence of the regulation of multiple miRNAs and their 
target genes, rather than of a single miRNA.
HIV-related lipodystrophy is associated with dicer downregulation 
in human adipose tissue. Many of the phenotypes observed in mice 
lacking dicer in adipose tissue, including loss of white fat, appear-
ance of increased interscapular fat, insulin resistance, dyslipidemia, 
increased resting energy expenditure, and increased markers of 
cardiovascular disease risk, are often observed in humans with 
Figure 5. Brown to white identity switch upon dicer KO in adipocytes. Immortalized interscapular brown preadipocytes of dicerfl/fl mice were transduced with 
adenoviruses harboring GFP (Lox) or Cre recombinase (dicer KO, denoted in the figure as KO), and 4 days later (day 0, D0), cells were differentiated in vitro into 
adipocytes (D8). (A) Adipocyte markers were assessed by qPCR (n = 3 per group). (B and C) Lipid accumulation during differentiation was measured using Oil 
Red O staining on day 8. Visualization at (B) lower (original magnification, ×1 scanning the bottom of the plate with an optical scanner) and (C) higher magni-
fications (original magnification, ×200 using an optical microscope). Representative images of 3 independent cell lines per group. (D) Differentiated cells were 
treated for 4 hours with 500 μM cAMP or 10 μM isoproterenol. Ucp1 mRNA expression was measured by qPCR, and fold induction versus the nonstimulated 
control was calculated (n = 3 per group). (E) Uncoupled respiration was measured using a Seahorse Bioscience XF24-3 Extracellular Flux Analyzer (n = 5 per 
group). Values represent the amount of O2 consumed by cells when incubated with the ATP synthase inhibitor oligomycin A. (F and G) Three days after aden-
oviral transduction, Lox and dicer-KO preadipocytes were transfected with miRNA mimics or a scramble, nonsilencing control (NS). Adipocyte differentiation 
started on the following day (D0), and (F) Ucp1 and (G) Cebpb mRNAs were measured by qPCR when cells were fully differentiated (D8) (n = 3 per group). In F 
and G, gene expression was normalized by aP2 mRNA levels to avoid small differences in adipocyte differentiation. *P < 0.05. Values are the mean ± SEM.
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cline in dicer with age specifically in adipose tissue. We found that 
whether initiated during development or in adult animals, KO of 
dicer in fat in mice impaired adipocyte determination, resulting in 
abnormal fat distribution, whitening of constitutive and inducible 
brown adipocytes, increased lean mass, and features of the met-
abolic syndrome. The change in BAT can be reproduced in vitro, 
i.e., it is cell autonomous and is partly due to changes in levels of 
miRNAs such as miR-365, miR-346, and miR-362. Thus, downreg-
ulation of dicer and miRNAs in adipocytes results in partial loss 
of adipocyte identity, bringing forth an important mechanism of 
regulation of adipocyte function and whole-body metabolism.
With the recent discovery that adult humans have brown fat and 
the potential to use this tissue to promote weight loss, much effort 
has been put forth to define how brown adipocytes are formed and 
the exact nature of their relationship to white adipocytes. Consider-
able data have been accumulated, indicating that brown, beige, and 
white adipocytes originate from different cell lineages and require 
distinct adipogenic stimuli to be formed (7, 53). However, some re-
cent studies suggest that the functional identity of adipocytes can 
also be set, at least in part, post-developmentally. Sanchez-Gur-
maches and colleagues have shown that adipocytes from the same 
depot might derive from different developmental origins but still 
share a singular identity, while adipocytes from different depots 
might share the same precursor lineage but differ in terms of func-
tion and morphology (8). Likewise, Rosenwald and colleagues have 
demonstrated that white and beige adipocytes interconvert bidirec-
tionally in the WAT of mice in response to different environmental 
cues (54). These results are consistent with the potential for trans-
differentiation to occur in at least some fraction of the adipocyte 
pool (55). Our results suggest that this post-developmental switch 
may involve reprogramming by miRNAs, since in mice, KO of dicer 
in mature adipocytes using adiponectin or aP2 promoter–directed 
abdominal fat (49). In the Boston cohort, dicer mRNA expression 
was reduced by over 75% in the dorsocervical adipose tissue of HIV 
patients compared with that in normal controls (Figure 6A). This 
was true whether subjects displayed more fat loss (subcutaneous 
lipoatrophy) or fat gain (visceral lipohypertrophy) (48). Indeed, in 
this cohort, none of the patients with HIV lipodystrophy had a dicer 
mRNA level as high as that of the lowest control. In the larger Finn-
ish cohort, dicer mRNA expression was also significantly reduced 
in the abdominal subcutaneous fat of HIV patients, although the 
magnitude of decrease in this area was less than that in the dors-
ocervical region (Figure 6B). Again, this decrease was independent 
of whether the patients had systemic lipoatrophy. Thus, down-
regulation of dicer in fat is a feature of humans with HIV, and this 
downregulation is more severe in certain adipose depots, such as 
the dorsocervical region, in which fat distribution is often abnormal.
Discussion
Brown and white adipocyte identity is defined during develop-
ment but can be modified by a myriad of complex events includ-
ing genetic factors, epigenetic factors, hormonal factors, and other 
environmental challenges that might occur during adipocyte dif-
ferentiation (50–52). miRNAs play a major role in maintaining cell 
identity by fine-tuning cell-specific transcriptional networks (19, 
20) and have been shown to play important roles in both brown 
and white fat differentiation (22, 24–29). miRNAs in adipose tis-
sue change in response to obesity, insulin resistance, or cold ex-
posure (24, 29), and there is an even more global change in the 
miRNA profile in fat with aging due to age-dependent downregu-
lation of dicer (30). The latter phenomenon is conserved in species 
from worms to humans and can be rescued by caloric restriction, 
suggesting it plays an important role in the regulation of longevity. 
Here, we created 2 mouse models to explore the role of the de-
Figure 6. Expression of dicer mRNA in adipose 
tissue of humans with HIV. (A) Expression of 
dicer mRNA in human dorsocervical subcutane-
ous adipose tissue of HIV-positive lipodystrophy 
patients and controls (Boston cohort: n = 6–14 
per group). Symbols represent the size of the 
tissue in relation to body weight. (B) Expression 
of dicer mRNA in human abdominal subcutane-
ous adipose tissue of HIV-positive lipodystrophy 
patients and controls (Finnish cohort: n = 27–60 
per group). Symbols represent the size of the 
tissue in relation to body weight. (C) Schematic 
model of factors that influence dicer expression 
in fat and its pathophysiological consequences. 
***P < 0.001. Values are the mean ± SEM. 
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ipose tissue can also lead to accelerated aging and lipodystrophy 
(63, 64). We now find that dicer is downregulated in the adipose 
tissue of patients with HIV and HIV-related partial lipodystro-
phy, and these individuals may exhibit signs of premature aging, 
metabolic syndrome (diabetes and dyslipidemia), cardiovascular 
disease, and increased sensitivity to stress (38). Whether patients 
with other forms of congenital or acquired lipodystrophy also have 
alterations in dicer expression in fat remains to be determined.
In summary, our findings indicate that dicer and miRNA pro-
cessing play a role in brown and white adipocyte determination. Our 
data also suggest that aging and metabolic diseases can act through 
downregulation of dicer in adipose tissue to shift fat determination 
toward insulin resistant, metabolically impaired white adipocytes, 
leading to features of the metabolic syndrome and, in some cases, 
a partial lipodystrophy syndrome (Figure 6C). Furthermore, our 
previous study indicates that caloric restriction can prevent the age- 
related decline in dicer expression and in miRNA processing in fat 
(30), and caloric restriction is known to reverse many features of the 
metabolic syndrome and improve longevity. These findings raise 
the possibility of using agents to increase dicer or specific miRNA 
expression in adipose tissue to treat features of the metabolic syn-
drome and some forms of the partial lipodystrophy syndrome.
Methods
Mice. Adipose-specific dicer-KO mice were generated by breeding dicerfl/fl 
mice with mice carrying an adiponectin promoter Cre transgene (30) or 
Cre recombinase driven by a tamoxifen-induced aP2 promoter (65). For 
the iaP2dicer-KO, tamoxifen (Sigma-Aldrich) treatment (3 mg once per 
week by gavage) was started in 3-month-old mice and continued until 
the mice were 8 months of age. All mice were maintained on a normal 
chow diet (Mouse Diet 9F; PharmaServ). Males were used for this study 
unless otherwise indicated. For some experiments, 8-week-old mice 
were given a 60% HFD (D12492; Research Diets) for 20 weeks. At sac-
rifice, tissues were collected, snap-frozen in N2, and stored at –80°C. For 
insulin stimulation, mice were anesthetized with Avertin and injected i.v. 
with either saline or 10 U of insulin (Humalog; Lilly). After 5 minutes, 
mice were sacrificed, and tissues were collected. Paraquat was injected 
i.p. at 6.5 mg/kg body weight, and survival was monitored periodically.
MRI. Mice were anesthetized using isoflurane/O2 (2.5/2.0%) 
10 minutes prior to and during the experiments. MR images were 
acquired on an Aspect M2 1T tabletop MRI scanner (Aspect Imaging).
Histological analyzes. Tissues were fixed in 10% formalin. Slides 
were stained with H&E or immunostained with UCP1 antibody (sc-
6528; Santa Cruz Biotechnology Inc.) or F4/80 antibody (ab6640; 
Abcam) and counterstained as described (53).
Metabolism studies. Glucose tolerance, insulin tolerance, and glu-
cose-stimulated insulin secretion tests were performed as previously 
described (66). Hyperinsulinemic-euglycemic clamps were performed 
in conscious mice as reported elsewhere (67). Serum parameters were 
determined by the Joslin Diabetes Center’s DERC assay core. Triglycer-
ide content was measured in liver and quadriceps muscle using the Tri-
glyceride Quantification kit (Abcam) and normalized by protein levels as 
determined by the Bradford reagent. Fat and lean mass were measured 
by DEXA scanning. Activity, food intake, O2 consumption, and CO2 pro-
duction were measured using the Oxymax OPTO-M3 system (Colum-
bus Instruments). O2 uptake (VO2) levels were normalized by lean mass 
as assessed by DEXA scanning. For cold exposure, mice were housed 
recombination (both of which are turned on in mid to late differenti-
ation; ref. 56) resulted in a marked adipocyte identity switch.
Creation of fat-specific dicer-KO mice also illustrates some of 
the important caveats of tissue-selective recombination in fat, as 
previously reported by us and others (35, 57). Thus, in our first at-
tempt to determine the role of dicer in adipose tissue, we created 
KO mice using aP2-Cre, and, as observed by Mudhasani et al. (34), 
these aP2-Cre dicerfl/fl mice die shortly after birth and are much 
smaller and more fragile than their littermate controls. This is al-
most certainly due to expression of the aP2-Cre transgene in non-
adipose tissues, including in germline cells and endothelial cells of 
the heart (35), where it has been shown that dicer KO is lethal (58, 
59). We therefore created and characterized 2 other mouse mod-
els of fat-specific dicer KO, which avoided the limitations brought 
by the aP2-Cre transgene. One model used the tamoxifen-induc-
ible aP2-Cre transgene, which allowed study of the effects of dicer 
KO in adult mice, but was limited in its effectiveness of recombi-
nation; the other model used an adiponectin-Cre transgene, which 
we have previously shown is truly exclusive to fat in its distribution 
and highly effective in inducing recombination (35).
Both of these latter models exhibited a clear phenotype of 
abnormal fat distribution with features of the HIV partial lipo-
dystrophy syndrome. This included a decrease in white fat in both 
the subcutaneous and intra-abdominal depots, enlargement of 
fat with characteristics that are intermediate between brown and 
white fat in the interscapular region, and signs of metabolic syn-
drome including insulin resistance, adipose tissue inflammation, 
dyslipidemia, increased resting energy expenditure, and increased 
markers of cardiovascular disease risk (36, 48). Interestingly, and 
consistent with this, dicer mRNA was significantly downregulated 
in adipose tissue of patients with HIV and HIV-related partial lipo-
dystrophy, linking dicer expression in fat to at least 1 syndrome of 
abnormal fat distribution in humans.
While changes in glucose and lipid homeostasis are expected 
in lipodystrophy, there are other systemic consequences of dicer 
downregulation in adipose tissue, including increased lean body 
mass, which were unexpected. While the exact mechanism of the 
latter is unknown at present, muscular hypertrophy is observed 
in some patients with both generalized and partial lipodystrophy 
(60–62). KO of dicer in fat also changes sensitivity to oxidative 
stress at the whole-body level in interesting ways. In very young 
mice, dicer KO increases sensitivity to paraquat (30), whereas in 
the present study, we found no change or perhaps mild resistance to 
paraquat toxicity in middle-aged and older mice. The changing re-
lation of paraquat sensitivity with aging may reflect the fact that in 
the control mice, dicer expression in fat decreases with age, making 
the difference between the control and KO mice less pronounced. 
Clearly, the exact mechanisms underlying these cell-nonautono-
mous effects of loss of dicer in fat will require further study.
Given the role of adipose tissue dicer in stress resistance and 
aging, it is important to consider how the physiological changes of 
our fat-specific dicer-KO models may be linked to the downregu-
lation of dicer expression in adipose tissue that has been observed 
in mice with aging (30) and in humans with HIV (this study). We 
have shown that oxidative stress downregulates dicer and that 
dicer KO leads to premature senescence in preadipocytes in vitro 
(30). Increased oxidative stress and premature senescence in ad-
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of the Helsinki University Central Hospital in Helsinki, Finland, as pre-
viously described (49). The samples were immediately frozen in liquid 
nitrogen and stored at –80°C until analysis. RNA was extracted using an 
RNeasy Mini Kit (QIAGEN). cDNA was prepared as described above for 
the dorsocervical samples and using a SuperScript VILO cDNA synthe-
sis kit (Life Technologies) for the abdominal samples. For the dorsocer-
vical samples, dicer expression was assessed by TaqMan qPCR (Applied 
Biosystems) and normalized to FAM-TBP (Applied Biosystems) (30). 
For the abdominal samples, dicer expression was measured using SYBR 
Green qPCR and normalized to the geometric mean of TBP and 36B4.
Statistics. Results are expressed as the mean ± SEM. For mouse stud-
ies, we used a 2-tailed Student’s t test for statistical analysis between 2 
groups and ANOVA when comparing more than 2 groups. The human 
study groups were compared using Fisher’s exact test for categorical 
variables and an unpaired t test or a Mann-Whitney U test, as appropri-
ate, for continuous variables. Statistical significance was set at P < 0.05.
Study approval. Protocols for animal use were approved by the 
IACUCs of the Joslin Diabetes Center and Brandeis University and were 
in accordance with NIH guidelines. The human studies were approved 
by the IRBs of Beth Israel Deaconess Medical Center, Joslin Diabetes 
Center, Massachusetts General Hospital, and Helsinki University. All 
patients or their guardians provided written informed consent.
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in a cold room at 6°C, and the temperature was measured periodically 
using a RET-3 rectal probe (Physitemp). Shivering was measured dur-
ing a period of 1 minute while the mouse was handled in the cold room. 
The assessment was subjective and based on the motion sensing of the 
operator while handling the animal. These assessments were always 
performed in triplicate by the same operator in a blinded fashion. For 
β3-adrenergic receptor stimulation in vivo, mice were injected i.p. with 
1 mg/kg CL-316,243 (Sigma-Aldrich). Adipocyte isolation, lipogenesis, 
and lipolysis assays were performed as previously described (66, 68).
Western blotting and qPCR. Cells or tissues were harvested and 
homogenized in radioimmunoprecipitation assay (RIPA) buffer con-
taining protease and phosphatase inhibitors (Pierce Biotechnology). 
Lysates (10–30 μg) were subjected to SDS-polyacrylamide gel elec-
trophoresis, transferred to a PVDF membrane (Thermo Fisher Sci-
entific), and immunoblotted with the appropriate antibodies (66). 
miRNA expression was determined using the miRNome miRNA PCR 
Array (SABiosciences, QIAGEN), and RT-qPCR was performed as pre-
viously described (30). The nucleotide sequences of the primers are 
shown in Supplemental Table 8.
Cell culture and adipocyte differentiation. Immortalized dicerfl/fl 
brown preadipocytes were transduced with an adenoviral Cre recom-
binase (30) and differentiation induced using a cocktail containing 
20 nM insulin, 1 nM triiodothyronine, 0.5 mM isobutylmethylx-
anthine, 1 μM dexamethasone, and 0.125 mM indomethacin (66). 
Reintroduction of miRNA mimics in dicer-KO cells was performed 
according to a previously published protocol (30). For stimulation of 
Ucp1 mRNA, differentiated cells were incubated with 500 μM dibu-
tyrul cAMP or 10 μM isoproterenol for 4 hours. Cellular respiration 
of preadipocytes was assessed using the Seahorse Bioscience XF24-3 
Extracellular Flux Analyzer as previously described (22).
GSEA. We used microarray expression data of dicer-KO and Lox 
immortalized preadipocytes available in the Gene Expression Omnibus 
(GEO) database (GEO GSE24683) (30). Enriched targets of miRNAs 
were sought among the genes upregulated in KO cells using the GSEA 
bioinformatics tool (Broad Institute).
Human studies. Two cohorts of patients were studied: a Boston 
cohort and a Finnish cohort. In the Boston cohort, sampling of dorsoce-
rvical fat was performed from patients with HIV recruited from the Beth 
Israel Deaconess Medical Center, the Joslin Diabetes Center, and the 
Massachusetts General Hospital (all in Boston), as previously described 
(48). In the Finnish cohort, biopsies of abdominal subcutaneous fat 
were obtained from patients recruited from the HIV outpatient clinic 
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